New drug BT-114143 passes first safety check in healthy volunteers
NCT ID NCT07169240
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage trial tested a single injection of BT-114143 in 84 healthy adults to see if it is safe and how the body handles it. Participants received different doses or a placebo, and researchers monitored side effects and drug levels in the blood. Since this is a Phase 1 study in healthy people, it does not test whether the drug treats any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BT-114143 injection
- What could go wrong
- This is a very early Phase 1 study in healthy people, so it cannot show whether BT-114143 works for any disease. The drug may cause side effects or fail in later trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS (HS) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
PKU Care Luzhong Hospital
Zibo, Shandong, 255499, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A two-session balance workout may cut fall risk in seniors
- Salty air: a new way to help lungs sweep themselves clean?
- First human test of SSGJ-626: will it be safe?
- Scientists to test how healthy bodies react to exercise in thin air
- Does stretching after weights change how your heart recovers?
- Could heart disease start outside the heart? new imaging study aims to find out